Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2022

01-04-2022 | Septicemia | IM - ORIGINAL

Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER)

Authors: David Spirk, Tim Sebastian, Jürg Hans Beer, Lucia Mazzolai, Drahomir Aujesky, Daniel Hayoz, Rolf Peter Engelberger, Wolfgang Korte, Nils Kucher, Stefano Barco

Published in: Internal and Emergency Medicine | Issue 3/2022

Login to get access

Abstract

We aimed to evaluate the impact of age, sex, and their interactions with provoking risk factors for deep vein thrombosis (DVT). In addition, we intended to provide additional insights on risk factors associated with the isolated distal versus proximal presentation of first symptomatic acute DVT, both being characterized by different prognosis. In the present analysis from the SWIss Venous ThromboEmbolism Registry (SWIVTER), we compared demographic and baseline characteristics in patients with isolated distal (n = 184; 35%) versus proximal (n = 346) DVT of the lower limbs without symptomatic pulmonary embolism, and identified factors related with the presenting thrombosis location. In the overall population, mean age was 59 ± 19 years, 266 (50%) were women, 106 (20%) patients had cancer, 86 (16%) recent surgery, and 52 (10%) acute infection/sepsis. In a multivariable analysis, recent surgery [odds ratio (OR) 2.92, 95% confidence interval (CI) 1.80–4.73] was independently associated with a diagnosis of isolated distal DVT, whereas cancer (OR 2.01, 95% CI 1.20–3.35), male sex aged 41 to 75 years (OR 2.21, 95% CI 1.33–3.67), and acute infection/sepsis (OR 2.71, 95% CI 1.29–5.66) with a diagnosis of proximal DVT. In SWIVTER, age, sex, and several provoking risk factors for VTE appeared to be related with the presenting location of first symptomatic DVT. Cancer, male sex, and acute infection/sepsis were associated with a proximal location of DVT, whereas recent surgery was associated with a distal presentation, likely acting as confounders for the association between thrombosis location and prognosis.
Literature
1.
go back to reference Kyrle PA, Kammer M, Eischer L, Weltermann A, Minar E, Hirschl M et al (2016) The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost 14(12):2402–2409CrossRefPubMed Kyrle PA, Kammer M, Eischer L, Weltermann A, Minar E, Hirschl M et al (2016) The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost 14(12):2402–2409CrossRefPubMed
2.
go back to reference Palareti G (2014) How I treat isolated distal deep vein thrombosis (IDDVT). Blood 123(12):1802–1809CrossRefPubMed Palareti G (2014) How I treat isolated distal deep vein thrombosis (IDDVT). Blood 123(12):1802–1809CrossRefPubMed
3.
go back to reference Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM et al (2019) Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 173:166–171CrossRefPubMed Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM et al (2019) Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thromb Res 173:166–171CrossRefPubMed
4.
go back to reference Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S et al (2018) Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 172:74–79CrossRefPubMed Trinchero A, Scheres LJJ, Prochaska JH, Ambaglio C, Wild PS, Middeldorp S et al (2018) Sex-specific differences in the distal versus proximal presenting location of acute deep vein thrombosis. Thromb Res 172:74–79CrossRefPubMed
6.
go back to reference Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352CrossRefPubMed Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352CrossRefPubMed
7.
go back to reference Barco S, Corti M, Trinchero A, Picchi C, Ambaglio C, Konstantinides SV et al (2017) Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost 15(7):1436–1442CrossRefPubMed Barco S, Corti M, Trinchero A, Picchi C, Ambaglio C, Konstantinides SV et al (2017) Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost 15(7):1436–1442CrossRefPubMed
8.
go back to reference Bauersachs RM, Riess H, Hach-Wunderle V, Gerlach H, Carnarius H, Eberle S et al (2010) Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thromb Haemost 103(4):710–717CrossRefPubMed Bauersachs RM, Riess H, Hach-Wunderle V, Gerlach H, Carnarius H, Eberle S et al (2010) Impact of gender on the clinical presentation and diagnosis of deep-vein thrombosis. Thromb Haemost 103(4):710–717CrossRefPubMed
9.
go back to reference Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG et al (2019) Isolated distal deep vein thrombosis: perspectives from the GARFIELD-VTE registry. Thromb Haemost 119(10):1675–1685CrossRefPubMed Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG et al (2019) Isolated distal deep vein thrombosis: perspectives from the GARFIELD-VTE registry. Thromb Haemost 119(10):1675–1685CrossRefPubMed
Metadata
Title
Role of age, sex, and specific provoking factors on the distal versus proximal presentation of first symptomatic deep vein thrombosis: analysis of the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Authors
David Spirk
Tim Sebastian
Jürg Hans Beer
Lucia Mazzolai
Drahomir Aujesky
Daniel Hayoz
Rolf Peter Engelberger
Wolfgang Korte
Nils Kucher
Stefano Barco
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02878-7

Other articles of this Issue 3/2022

Internal and Emergency Medicine 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine